+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID07844590

Early Detection of Respiratory Problems in ALS Using Breathing Tests, MRI, and Blood Markers

Led by Thomas Jefferson University · Updated on 2026-09-28

70

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to find new ways to detect early changes linked to amyotrophic lateral sclerosis ALS, also called Lou Gehrigs disease. The study will investigate if changes in automatic breathing, brainstem and spinal cord imaging, and blood markers can identify early signs of ALS before major physical symptoms develop. It includes people with ALS, those with genetic risk but no symptoms, and healthy adults for comparison. Participants are divided into three groups those with symptomatic ALS, those carrying a genetic risk for ALS without symptoms, and healthy controls without neurological issues. Each group will undergo breathing and muscle function tests, magnetic resonance imaging MRI scans of the brainstem and spinal cord, and blood tests to examine biomarkers related to ALS. During a single study visit, participants will complete respiratory function tests, MRI scans, and blood sampling. The research team will measure the accuracy of a breathing impairment risk score for detecting ALS-related respiratory problems and assess MRI and blood biomarker levels. This observational study involves no treatment and aims to improve early diagnosis methods for ALS.

CONDITIONS

Brief Title

Developing New Ways to Detect Respiratory Impairment Early in ALS

Research Team

J

Jayakrishnan Nair, PhD, PT

D

Dana Johnson, DPT

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here